Press background on Balaxi Pharmaceuticals Limited
Company profile
Balaxi Pharmaceuticals Ltd. is a branded IPR-based pharmaceutical player focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. The Company is engaged in supplying branded and generic medicines through its well-built on ground infrastructure across Angola, Guatemala and Dominican Republic. These products are procured from WHO GMP certified contract manufacturers based in India, China and Portugal.
Revenue growth of 40.3% on YoY basis, with operating EBITDA of Rs. 15.29 crore
PAT stood at Rs. 8.23 crore
Revenue from Pharmaceutical business grew by 40.4% Y-o-Y
Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical compan... (more)
Feb 01, 2023 17:23 IST
Balaxi Pharmaceuticals Limited
Revenue up 23%, Profit After Tax expands 29%
Pharma revenue up 50% with expanding contribution from Latin America
Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the second qu... (more)
Nov 07, 2022 11:45 IST
Balaxi Pharmaceuticals Limited
Revenue grows 42% in Q1FY23.
​Pharma Revenue in Latin America up 39%.
Profit After Tax up 32% YoY.
Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first qua... (more)
Aug 03, 2022 13:05 IST
Balaxi Pharmaceuticals Limited
